Responses
Psoriatic arthritis
Original research
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies
Compose a Response to This Article
Other responses
No responses have been published for this article.